← board
INVA
distress 0/10 · well-funded / low risk$21.15-1%today-13% from 52w high
Revenue
$98M
Liquidity
$1016M
Runway
—
Shares 1y
+17%
Price & events
+7.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.3%
1D
-4.8%
1W
-10.2%
1M
-9.9%
3M
+8.1%
6M
+9.7%
1Y
+18.7%
2Y
+58.3%
5Y
+69.5%
All
Overview
- Market Cap
- $1.56B
- Enterprise Value
- $1.22B
- Volume
- 29.57K
- 52 Week Range
- $16.67 – $24.24
- Total Shares
- 73.81M
- Float Shares
- 69.20M
- Short %
- 12.13%
- % Held by Insiders
- 0.99%
- % Held by Institutions
- 107.92%
- RVOL
- 0.04x
- Beta
- 0.34
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-05Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 73,808,749 · 0 offerings/1y · 0 PIPEs
- 2024-11-14SC 13D/Astrategic_stake
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
buy · target $36 (+68% upside) · 4 analysts
- 2026-06-22BTIGBuy
- 2026-06-01HC Wainwright & Co.Buy
- 2026-05-26BTIGBuy
- 2026-05-07BTIGBuy
- 2026-02-26BTIGBuy
- 2026-02-17BTIGBuy
Competitors
- none identified
Recent news
- 2026-07-19How Innoviva Inc. (INVA) Affects Rotational Strategy Timing - Stock Traders Daily
- 2026-07-06Enterprise value to EBITDA forward of Innoviva, Inc. – SWB:HVE - TradingView
- 2026-07-05Innoviva Inc. (INVA) Sees Modest Uptick, Testing Resistance Near $23.43 - Safe Entry Stocks - dars.gov.et
- 2026-07-03Is Innoviva (INVA) Trading Index Membership for a Deeper Bet on Nortiva Bio’s LYNX Platform? - simplywall.st
- 2026-07-01Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now? - Yahoo Finance
- 2026-06-28Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
- 2026-06-27INVA Forecast — Price Target — Prediction for 2027 - TradingView
- 2026-06-25Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform - Yahoo Finance
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.